AU8748798A - 4-aminoquinazoline derivatives - Google Patents
4-aminoquinazoline derivativesInfo
- Publication number
- AU8748798A AU8748798A AU87487/98A AU8748798A AU8748798A AU 8748798 A AU8748798 A AU 8748798A AU 87487/98 A AU87487/98 A AU 87487/98A AU 8748798 A AU8748798 A AU 8748798A AU 8748798 A AU8748798 A AU 8748798A
- Authority
- AU
- Australia
- Prior art keywords
- aminoquinazoline derivatives
- aminoquinazoline
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9-225963 | 1997-08-22 | ||
| JP22596397 | 1997-08-22 | ||
| PCT/JP1998/003711 WO1999009986A1 (en) | 1997-08-22 | 1998-08-21 | 4-aminoquinazoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU8748798A true AU8748798A (en) | 1999-03-16 |
Family
ID=16837636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU87487/98A Abandoned AU8748798A (en) | 1997-08-22 | 1998-08-21 | 4-aminoquinazoline derivatives |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU8748798A (en) |
| WO (1) | WO1999009986A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1242993C (en) * | 2000-03-31 | 2006-02-22 | 日本新药株式会社 | Heterocycle derivatives and drugs |
| CN1474815A (en) * | 2000-09-20 | 2004-02-11 | Ĭ��ר���ɷ�����˾ | 4-amino-quinazoline |
| EP1318985A2 (en) * | 2000-09-20 | 2003-06-18 | MERCK PATENT GmbH | 4-amino-quinazolines |
| JPWO2002036577A1 (en) | 2000-11-02 | 2004-03-11 | 日本新薬株式会社 | Quinazoline derivatives and pharmaceuticals |
| WO2002062767A1 (en) * | 2001-02-07 | 2002-08-15 | Sumitomo Pharmaceuticals Company, Limited | Novel quinazoline derivatives |
| US7829566B2 (en) | 2001-09-17 | 2010-11-09 | Werner Mederski | 4-amino-quinazolines |
| CN1665791A (en) * | 2002-07-05 | 2005-09-07 | 霍夫曼-拉罗奇有限公司 | Quinazoline derivatives |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| KR101218213B1 (en) | 2003-07-03 | 2013-01-04 | 시토비아 인크. | 4--4-Arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| CA2545340A1 (en) | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Fused heterocyclic compounds |
| EP1833482A4 (en) | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | NITROGEN BICYCLIC COMPOUNDS AND THERAPEUTIC USE THEREOF |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| EP3027605B1 (en) * | 2013-07-31 | 2017-11-08 | Council of Scientific & Industrial Research | Novel indazole compounds and a process for the preparation thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61100593A (en) * | 1984-10-03 | 1986-05-19 | Sankyo Co Ltd | Griseolic acid derivative |
| BR9611210A (en) * | 1995-10-23 | 1999-12-28 | Zymogenetics Inc | Compositions and processes for treating deficient bone conditions |
-
1998
- 1998-08-21 AU AU87487/98A patent/AU8748798A/en not_active Abandoned
- 1998-08-21 WO PCT/JP1998/003711 patent/WO1999009986A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999009986A1 (en) | 1999-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1151099A (en) | Azaoxindole derivatives | |
| AU1825899A (en) | Dota-biotin derivatives | |
| AU1709299A (en) | Mixer-injectors | |
| AU7935398A (en) | Diaminorhodamine derivatives | |
| AU8921698A (en) | Follistatin-3 | |
| AU6117998A (en) | 3-oxadiazolylquinoxaline derivatives | |
| AU9414098A (en) | Ascorbyl-phosphoryl-cholesterol | |
| AU6598798A (en) | Resorcinyl-triazines | |
| AU1027499A (en) | 32P-polyphosphazene | |
| AU9513298A (en) | Fluoranthenopyrans | |
| AU5272198A (en) | EMP-charge-eliminator | |
| AU8748798A (en) | 4-aminoquinazoline derivatives | |
| AU7813598A (en) | Betulinol derivatives | |
| AU6998698A (en) | Dioxacycloalkan-8-one | |
| AU4117497A (en) | Micropolarimeter | |
| AU6729498A (en) | Thiazolimine derivatives | |
| AU1174199A (en) | Biphenylamidine derivatives | |
| AU6185898A (en) | Clavaspirins | |
| AU8214598A (en) | 3-benzylpiperidine | |
| AU7761998A (en) | Korrosionsschutzanstrichstoff | |
| AU1562199A (en) | Amino-benzothiazole derivatives | |
| AU6115798A (en) | Saponarin derivatives | |
| AU1691399A (en) | 5-arylpyrrole derivatives | |
| AU9538898A (en) | Pyrrolopyrrolone derivatives | |
| AU8991998A (en) | Renovative pipeliner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |